PubRank

A Taketomi

Author PubWeight™ 49.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Feasibility of left lobe living donor liver transplantation between adults: an 8-year, single-center experience of 107 cases. Am J Transplant 2006 1.57
2 Diacylglycerol kinase epsilon regulates seizure susceptibility and long-term potentiation through arachidonoyl- inositol lipid signaling. Proc Natl Acad Sci U S A 2001 1.51
3 Impact of human T cell leukemia virus type 1 in living donor liver transplantation. Am J Transplant 2012 1.39
4 The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma. Cancer 1993 1.29
5 Left lobe living donor liver transplantation in adults. Am J Transplant 2012 1.26
6 Xanthogranulomatous cholecystitis masquerading as gallbladder carcinoma. Am J Gastroenterol 1994 1.22
7 A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995 1.18
8 Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer. Br J Cancer 2012 1.17
9 Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein. Cancer 1994 1.16
10 Diffuse bone metastasis with hematologic disorders from gastric cancer: clinicopathological features and prognosis. Oncol Rep 1999 1.09
11 Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996 1.04
12 Generation and elimination of 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate, a mutagenic substrate for DNA synthesis, in human cells. Biochemistry 1995 1.02
13 Morbidity and mortality after hepatic resection in the modern era. Hepatogastroenterology 1996 1.01
14 Family aggregation of carcinoma of the hypopharynx and cervical esophagus: special reference to multiplicity of cancer in upper aerodigestive tract. Int J Cancer 1998 0.98
15 Characteristics of hepatocellular carcinoma originating in the caudate lobe. Hepatology 1994 0.97
16 Modulation of CD4⁺ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis. Clin Exp Immunol 2011 0.94
17 Domain analysis of the actin-binding and actin-remodeling activities of drebrin. Exp Cell Res 1999 0.92
18 Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 1994 0.91
19 Living donor liver transplantation using dual grafts from two donors: a feasible option to overcome small-for-size graft problems? Am J Transplant 2008 0.91
20 Deceleration of regenerative response improves the outcome of rat with massive hepatectomy. Am J Transplant 2010 0.89
21 Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation. Br J Surg 2011 0.88
22 Donor age in living donor liver transplantation. Transplant Proc 2008 0.87
23 Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour. Histopathology 2006 0.86
24 [A review of Japanese literatures concerning surgery for lung cancer with idiopathic interstitial pneumonia]. Kyobu Geka 2002 0.86
25 The clinicopathological characteristics and outcome of patients with right colon cancer. Oncol Rep 1998 0.85
26 Renin-producing hepatoblastoma. J Pediatr Hematol Oncol 2000 0.84
27 Thrombomodulin inhibits intrahepatic spread in human hepatocellular carcinoma. Hepatology 1995 0.84
28 Estimation of standard liver volume for Japanese adults. Transplant Proc 2008 0.84
29 Influence of blood transfusion on postoperative long-term liver function in patients with hepatocellular carcinoma. Hepatogastroenterology 1996 0.83
30 Multiple primary colorectal and gastric carcinoma in Japan. Oncol Rep 1998 0.83
31 Expression profiles of genes associated with viral entry in HCV-infected human liver. J Med Virol 2011 0.83
32 Sequential methothrextate and 5-fruororacil therapy for diffuse bone metastasis from gastric cancer. Anticancer Res 1998 0.82
33 Occurrence of intraperitoneal septic complications after hepatic resections between 1985 and 1990. Surg Today 1995 0.81
34 Successful ABO incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin. Transplant Proc 2007 0.81
35 Human early liver regeneration after hepatectomy in patients with hepatocellular carcinoma: special reference to age. Scand J Surg 2013 0.80
36 Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway. Int J Clin Pharmacol Ther 2010 0.80
37 The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C. Transplant Proc 2009 0.80
38 Multifocal occurrence of gastric carcinoma in patients with a family history of gastric carcinoma. Cancer 1998 0.80
39 Simplified inflow control using stapling devices for major hepatic resection. Arch Surg 1996 0.79
40 Cell proliferation and cell loss in nodule-in-nodule hepatocellular carcinoma. Hepatogastroenterology 1999 0.79
41 Rho-kinase as a novel gene therapeutic target in treatment of cold ischemia/reperfusion-induced acute lethal liver injury: effect on hepatocellular NADPH oxidase system. Gene Ther 2007 0.79
42 The role of interleukin-6, interleukin-16, tumor necrosis factor-alpha and endotoxin in hepatic resection. Hepatogastroenterology 1996 0.78
43 Multi-forms of human MTH1 polypeptides produced by alternative translation initiation and single nucleotide polymorphism. Nucleic Acids Res 1999 0.78
44 Retrograde right hepatic trisegmentectomy. Surgery 1996 0.78
45 Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma. Hepatology 1998 0.78
46 Prognosis of well differentiated small hepatocellular carcinoma--is well differentiated hepatocellular carcinoma clinically early cancer? Hepatogastroenterology 1996 0.78
47 Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma. Surgery 1995 0.77
48 A new approach for liver surgery. Transdiaphragmatic hepatectomy for cirrhotic patients with hepatocellular carcinoma. Arch Surg 1995 0.77
49 Rapid normalization of portopulmonary hypertension after living donor liver transplantation. Transplant Proc 2009 0.77
50 Levels of amino acids in human hepatocellular carcinoma and adjacent liver tissue. Nutr Cancer 1995 0.77
51 Influence of viral hepatitis status on operative morbidity and mortality in patients with primary hepatocellular carcinoma. Br J Surg 1994 0.77
52 Submucosal gastric cancer with lymph node metastasis. J Surg Oncol 1998 0.77
53 The role of prostaglandins in hepatic resection. Prostaglandins Leukot Essent Fatty Acids 1994 0.76
54 The impact of IL28B genetic variants on recurrent hepatitis C in liver transplantation: significant lessons from a dual graft case. Am J Transplant 2011 0.76
55 The role of growth hormone, somatostatin and glucagon in hepatic resection. Hepatogastroenterology 1998 0.76
56 Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection. J Am Coll Surg 1994 0.75
57 Major hepatic resection in patients with a prosthetic heart valve receiving anticoagulation treatment. Hepatogastroenterology 1994 0.75
58 Inguinal lymph node recurrence of mucosal cancer of the stomach. Oncol Rep 2011 0.75
59 The prediction of portal pressure: a multivariate analysis of clinical data and intraoperative portal pressure. Surg Today 1994 0.75
60 Second primary extracolonic cancers in Japanese hereditary nonpolyposis colorectal cancer. Oncol Rep 1998 0.75
61 Beneficial or adverse effects of hepatectomy vs. ethanol injection therapy in RBT-1 carcinoma of the rat liver. Hepatology 1994 0.75
62 ["Pulse" methylprednisolone therapy in children with idiopathic thrombocytopenic purpura]. Rinsho Ketsueki 1985 0.75
63 [Continuous hepatic arterial infusion chemotherapy with low-dose CDDP plus 5-FU for liver metastases from colorectal carcinoma]. Gan To Kagaku Ryoho 1996 0.75
64 Portal vein replacement by a synthetic graft in hepatic resection. J Vasc Surg 1995 0.75
65 Detection of hepatitis C virus RNA in the ultrasonic dissector irrigating solution used in liver surgery. Br J Surg 1994 0.75
66 Changing site distribution of Japanese colorectal cancer. Oncol Rep 2011 0.75
67 Images of interest. Hepatobiliary and pancreatic: peritoneal dissemination mimicking liver metastases. J Gastroenterol Hepatol 2004 0.75
68 Outpatient follow-up system using a personal computer for patients with hepatocellular carcinoma after surgery. J Med Syst 1994 0.75
69 Renal function after elective hepatic resection. Hepatogastroenterology 1997 0.75
70 [Pyrimidine nucleoside phosphorylase activity, 5-fluorouracil concentration and thymidylate synthase inhibition rate in colorectal cancer after oral administration of 5'-doxifluridine]. Gan To Kagaku Ryoho 1997 0.75
71 Sequential pancreaticoduodenectomy after living donor liver transplantation for cholangiocarcinoma. Am J Transplant 2008 0.75
72 Strategies for intractable ascites after hepatic resection: analysis of two cases. Br J Clin Pract 1995 0.75
73 Initiation of a fibrinolytic system in hepatic resection: the roles of tissue-type plasminogen activator and plasminogen activator inhibitor-1. Surg Today 1994 0.75
74 Evolving strategies to prevent biliary strictures after living donor liver transplantation. Transplant Proc 2010 0.75
75 End-stage liver cirrhosis with severe autoimmune hemolytic anemia, treated by blood type-incompatible living donor liver transplantation: a case report. Transplant Proc 2011 0.75